CSL says an agreement will support lower pricing for its therapy and reflects a
planned $1.5 billion investment to expand production capacity in Illinois, US.
The company expects no material impact in fiscal 2027.
2026-09-01
CSL says an agreement will support lower pricing for its therapy and reflects a
planned $1.5 billion investment to expand production capacity in Illinois, US.
The company expects no material impact in fiscal 2027.